{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:48:58Z","timestamp":1792082938476,"version":"4.4.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRM Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114703","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T20:53:08Z","timestamp":1745873588000},"page":"114703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A review on animal venom-based matrix metalloproteinase modulators and their therapeutic implications"],"prefix":"10.1016","volume":"157","author":[{"given":"Ansumaan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshad","family":"Balde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasool Abdul","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3390\/cells9051151","article-title":"Functional roles of matrix metalloproteinases and their inhibitors in melanoma","volume":"9","author":"Napoli","year":"2020","journal-title":"Cells"},{"issue":"31","key":"10.1016\/j.intimp.2025.114703_bb0010","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.2174\/092986710793213724","article-title":"Matrix metalloproteinases","volume":"17","author":"Z\u00edtka","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2025.114703_bb0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.matbio.2015.03.002","article-title":"Matrix remodeling by MMPs during wound repair","volume":"44","author":"Rohani","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.intimp.2025.114703_bb0020","article-title":"Matrix metalloproteinases\u2013an overview","volume":"1-20","author":"Sekton","year":"2010","journal-title":"Res. Report. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0025","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(98)80122-1","article-title":"Matrix metalloproteinases","volume":"2","author":"Johnson","year":"1998","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0030","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5603\/FHC.2012.0002","article-title":"The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer","volume":"50","author":"Groblewska","year":"2012","journal-title":"Folia Histochem. Cytobiol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.mam.2008.05.002","article-title":"Progress in matrix metalloproteinase research","volume":"29","author":"Murphy","year":"2008","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0045","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/cells9051076","article-title":"Structure and function of human matrix metalloproteinases","volume":"9","author":"Laronha","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/jcm9020472","article-title":"Matrix metalloproteinases in diabetic kidney disease","volume":"9","author":"Garcia-Fernandez","year":"2020","journal-title":"J. Clin. Med."},{"issue":"24","key":"10.1016\/j.intimp.2025.114703_bb0060","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114703_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-94-007-6458-3_16","article-title":"Evolutionary context of venom in animals","volume":"24","author":"Arbuckle","year":"2017","journal-title":"Evolut. Venom. Anim. Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0070","series-title":"Seeing the Woods for the Trees: Understanding Venom Evolution as a Guide for Biodiscovery","author":"Fry","year":"2015"},{"issue":"11","key":"10.1016\/j.intimp.2025.114703_bb0075","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/toxins11110666","article-title":"The diversity of venom: the importance of behavior and venom system morphology in understanding its ecology and evolution","volume":"11","author":"Schendel","year":"2019","journal-title":"Toxins"},{"issue":"23","key":"10.1016\/j.intimp.2025.114703_bb0080","doi-asserted-by":"crossref","first-page":"16862","DOI":"10.1074\/jbc.M113.464750","article-title":"Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin","volume":"288","author":"Vu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114703_bb0085","article-title":"Bioactive molecules derived from snake venoms with therapeutic potential for the treatment of thrombo-cardiovascular disorders associated with COVID-19","volume":"1-43","author":"Cherifi","year":"2021","journal-title":"Protein J."},{"key":"10.1016\/j.intimp.2025.114703_bb0090","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fphar.2020.01132","article-title":"From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery","volume":"11","author":"Bordon","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.intimp.2025.114703_bb0095","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1039\/C6AN00327C","article-title":"A single-label fluorescent derivatization method for quantitative determination of neurotoxin in vivo by capillary electrophoresis coupled with laser-induced fluorescence detection","volume":"141","author":"Chen","year":"2016","journal-title":"Analyst"},{"issue":"10","key":"10.1016\/j.intimp.2025.114703_bb0100","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/toxins11100564","article-title":"Snake venoms in drug discovery: valuable therapeutic tools for life saving","volume":"11","author":"Mohamed Abd El-Aziz","year":"2019","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrm763","article-title":"Matrix metalloproteinases: a tail of a frog that became a prince","volume":"3","author":"Brinckerhoff","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biocel.2004.06.017","article-title":"MMP-1: the elder of the family","volume":"37","author":"Pardo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"47","key":"10.1016\/j.intimp.2025.114703_bb0115","doi-asserted-by":"crossref","first-page":"14886","DOI":"10.1021\/acs.jafc.2c05931","article-title":"Relationships of matrix metalloproteinase 1 and a tissue inhibitor of metalloproteinase to collagen metabolism in Haliotis discus hannai","volume":"70","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/jiab167","article-title":"Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19","volume":"224","author":"Syed","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0125","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s10238-022-00897-y","article-title":"Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma","volume":"23","author":"Xu","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2025.114703_bb0130","article-title":"Matrix metalloproteinases","volume":"173-224","author":"Nagase","year":"1996","journal-title":"Zinc Metalloproteases Health and Diseas."},{"issue":"8","key":"10.1016\/j.intimp.2025.114703_bb0135","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/ph15080920","article-title":"Matrix metalloproteinase 2 as a pharmacological target in heart failure","volume":"15","author":"Gon\u00e7alves","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.intimp.2025.114703_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.663978","article-title":"Matrix metalloproteinase 3: a promoting and destabilizing factor in the pathogenesis of disease and cell differentiation","volume":"12","author":"Wan","year":"2021","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0145","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/S0021-9258(19)50563-4","article-title":"Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9","volume":"267","author":"Ogata","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0150","article-title":"Matrix metalloproteinases and their multiple roles in Alzheimer\u2019s disease","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2025.114703_bb0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.003","article-title":"Roles of matrix metalloproteinase-7 (MMP-7) in cancer","volume":"92","author":"Liao","year":"2021","journal-title":"Clin. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114703_bb0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imbio.2004.04.005","article-title":"The role of matrix metalloproteinase 7 in innate immunity","volume":"209","author":"Burke","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2025.114703_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0379-0","article-title":"NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7","volume":"14","author":"Banskota","year":"2015","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2025.114703_bb0170","doi-asserted-by":"crossref","first-page":"9140","DOI":"10.18632\/oncotarget.3274","article-title":"By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization","volume":"6","author":"Guan","year":"2015","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.intimp.2025.114703_bb0175","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.3390\/ijms20184506","article-title":"The role of MMP8 in cancer: a systematic review","volume":"20","author":"Juurikka","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cytogfr.2006.04.001","article-title":"Matrix metalloproteinase-8: cleavage can be decisive","volume":"17","author":"Van Lint","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.intimp.2025.114703_bb0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/CIRCRESAHA.109.200279","article-title":"A role of matrix metalloproteinase-8 in atherosclerosis","volume":"105","author":"Laxton","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2025.114703_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116116","article-title":"The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms","volume":"171","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0195","first-page":"7369020","article-title":"Matrix metalloproteinase 9 in epilepsy: the role of neuroinflammation in seizure development","volume":"2016","author":"Bronisz","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0200","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00414-024-03243-x","article-title":"Expression of matrix metalloproteinase-9 (MMP-9) in human skin within 1 hour after injury through immunohistochemical staining: a pilot study","volume":"138","author":"Cecchi","year":"2024","journal-title":"Int. J. Legal Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0205","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1158\/1055-9965.EPI-07-2840","article-title":"Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer","volume":"17","author":"Sauter","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.intimp.2025.114703_bb0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1874192401105010110","article-title":"Relationship between MMP-1, MMP-9, TIMP-1, IL-6 and risk factors, clinical presentation, extent and severity of atherosclerotic coronary artery disease","volume":"5","author":"Tanindi","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.intimp.2025.114703_bb0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12038-009-0035-1","article-title":"MMP-1 polymorphism and its relationship to pathological processes","volume":"34","author":"Arakaki","year":"2009","journal-title":"J. Biosci."},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0220","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.bjc.6601238","article-title":"Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma","volume":"89","author":"Talvensaari-Mattila","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/liv.12237","article-title":"MMP-2 is a disease-modifying gene in primary sclerosing cholangitis","volume":"34","author":"Sebib Korkmaz","year":"2014","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0230","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/ijms18040776","article-title":"MMP-2 and 9 in chronic kidney disease","volume":"18","author":"Cheng","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0235","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1440-1746.2010.06504.x","article-title":"Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer","volume":"26","author":"Park","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0240","first-page":"166","article-title":"Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies","volume":"29","author":"Wang","year":"2014","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.intimp.2025.114703_bb0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10585-005-8115-6","article-title":"Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model","volume":"22","author":"Mendes","year":"2005","journal-title":"Clin. Exp. Metastasis"},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.berh.2019.01.006","article-title":"MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis","volume":"32","author":"Lerner","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0255","article-title":"Matrix metalloproteinase\u20137 (MMP-7) and its biodiversity in health and disease: A comprehensive literature review","volume":"36","author":"Panda","year":"2023","journal-title":"J. Int. Med. Sci. Acad."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cytogfr.2011.02.002","article-title":"Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression","volume":"22","author":"Dejonckheere","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0265","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3390\/md11062069","article-title":"Protease inhibitors from marine venomous animals and their counterparts in terrestrial venomous animals","volume":"11","author":"Mour\u00e3o","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2025.114703_bb0270","series-title":"Veterinary Toxicology","first-page":"781","article-title":"Terrestrial zootoxins","author":"Gwaltney-Brant","year":"2018"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4331\/wjbc.v6.i2.28","article-title":"Animal venom studies: current benefits and future developments","volume":"6","author":"Utkin","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.114703_bb0280","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bcp.2017.03.005","article-title":"Animal venoms as antimicrobial agents","volume":"134","author":"Samy","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/ARRB\/2018\/45028","article-title":"A review on bioactivities of honey bee venom","volume":"30","author":"Azam","year":"2019","journal-title":"Ann. Res. & Rev. Biol."},{"key":"10.1016\/j.intimp.2025.114703_bb0290","first-page":"149","article-title":"Hymenoptera venom review focusing on Apis mellifera","volume":"9","author":"De Lima","year":"2003","journal-title":"J. Venom. Anim. Toxins Includ. Trop. Diseas."},{"issue":"01","key":"10.1016\/j.intimp.2025.114703_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/0001-3765201520130511","article-title":"Antimicrobial activity of apitoxin, melittin and phospholipase A2 of honey bee (Apis mellifera) venom against oral pathogens","volume":"87","author":"Leandro","year":"2015","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.intimp.2025.114703_bb0300","doi-asserted-by":"crossref","first-page":"1137547","DOI":"10.3389\/fchem.2023.1137547","article-title":"Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: current status and future directions","volume":"11","author":"Ye","year":"2023","journal-title":"Front. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0305","doi-asserted-by":"crossref","first-page":"2100060","DOI":"10.1002\/ardp.202100060","article-title":"Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms","volume":"354","author":"Li","year":"2021","journal-title":"Arch. Pharm."},{"issue":"9","key":"10.1016\/j.intimp.2025.114703_bb0310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113130","article-title":"A review on inflammation modulating venom proteins\/peptide therapeutics and their delivery strategies: A review","volume":"142","author":"Hemajha","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0320","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/15569543.2018.1530681","article-title":"Nature and applications of scorpion venom: an overview","volume":"39","author":"Tobassum","year":"2020","journal-title":"Toxin Rev."},{"key":"10.1016\/j.intimp.2025.114703_bb0325","article-title":"Spider venom peptides as potential drug candidates due to their anticancer and antinociceptive activities","volume":"25","author":"Wu","year":"2019","journal-title":"J. Venom. Anim. Toxins Includ. Trop. Diseas."},{"issue":"12","key":"10.1016\/j.intimp.2025.114703_bb0330","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/toxins2122851","article-title":"Spider-venom peptides as therapeutics","volume":"2","author":"Saez","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0335","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s10989-021-10276-y","article-title":"Crab pentapeptide and its anti-inflammatory activity on macrophage cells","volume":"27","author":"Balde","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10989-023-10552-z","article-title":"Purification and identification of bioactive oligopeptide from Indian halibut (Psettodes erumei) muscle tissue and its inflammation suppressing effect in vitro","volume":"29","author":"Balde","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0345","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1080\/10942912.2010.517342","article-title":"In vitro antioxidant and antiproliferative activities of bioactive peptide isolated from Nemipterus Japonicus backbone","volume":"15","author":"Naqash","year":"2012","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.intimp.2025.114703_bb0350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10989-011-9260-1","article-title":"Radical scavenging activity of seela (Sphyraena barracuda) and ribbon fish (Lepturacanthus savala) backbone protein hydrolysates","volume":"17","author":"Nazeer","year":"2011","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.intimp.2025.114703_bb0355","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijbiomac.2021.02.074","article-title":"Jellyfish venom proteins and their pharmacological potentials: A review","volume":"176","author":"Nisa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2025.114703_bb0360","article-title":"A review on anti-inflammatory and antioxidant peptides derived from marine organisms: mechanism of action and therapeutic applications","volume":"105745","author":"Jegani","year":"2024","journal-title":"Food Biosci."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0365","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/md17060325","article-title":"Sea anemone toxins: A structural overview","volume":"17","author":"Madio","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2025.114703_bb0370","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fevo.2019.00320","article-title":"Coral venom toxins","volume":"7","author":"Schmidt","year":"2019","journal-title":"Front. Ecol. Evol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0375","first-page":"25","article-title":"Some toxicological chemicalcharacteristics of three venomous soft corals from the Red Sea","volume":"132","author":"Radwan","year":"2002","journal-title":"Comparat. Biochemi. Physiol. Part C: Toxicol. & Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114703_bb0380","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.31557\/APJCP.2021.22.12.3913","article-title":"Anti-breast cancer activity on MCF-7 cells of melittin from Indonesia\u2019s Apis cerana: an in vitro study","volume":"22","author":"Lischer","year":"2021","journal-title":"Asian Paci. J. Cancer Prevent. APJCP"},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0385","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsps.2022.11.008","article-title":"Pharmacological properties and therapeutic potential of honey bee venom","volume":"31","author":"Ullah","year":"2023","journal-title":"Saudi Pharmaceut. J."},{"key":"10.1016\/j.intimp.2025.114703_bb0390","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12016-017-8597-4","article-title":"Immunology of bee venom","volume":"54","author":"Elieh Ali Komi","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0395","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/toxins13050337","article-title":"Bee venom components as therapeutic tools against prostate cancer","volume":"13","author":"Badawi","year":"2021","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0400","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/molecules24050929","article-title":"Bee venom and its peptide component melittin suppress growth and migration of melanoma cells via inhibition of PI3K\/AKT\/mTOR and MAPK pathways","volume":"24","author":"Lim","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0405","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jep.2009.12.007","article-title":"Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK\/p38 and NF-\u03baB-dependent mechanisms","volume":"127","author":"Cho","year":"2010","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0410","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/00218839.2007.11101374","article-title":"Inhibitory effect of bee venom against ultraviolet B induced MMP-11 and MMP-3 in human dermal fibroblasts","volume":"46","author":"Han","year":"2007","journal-title":"J. Apic. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0415","first-page":"324","article-title":"Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells","volume":"27","author":"Sisakht","year":"2017","journal-title":"Rev. Bras"},{"key":"10.1016\/j.intimp.2025.114703_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.792970","article-title":"Bee venom effect on glioblastoma cells viability and gelatinase secretion","volume":"16","author":"Ma\u0142ek","year":"2022","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0425","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/08923970500418943","article-title":"Bee venom, immunostimulant or immunosuppressor? Insight into the effect on matrix metalloproteinases and interferons","volume":"27","author":"Hamedani","year":"2005","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0430","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/molecules26010148","article-title":"Bee venom in wound healing","volume":"26","author":"Kurek-G\u00f3recka","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.114703_bb0435","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-011-9339-3","article-title":"Bee venom in cancer therapy","volume":"31","author":"Or\u0161oli\u0107","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.intimp.2025.114703_bb0440","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5487\/TR.2015.31.1.033","article-title":"Improved therapeutic profiles of PLA 2-free bee venom prepared by ultrafiltration method","volume":"31","author":"Lee","year":"2015","journal-title":"Toxicol. Res."},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0445","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/toxins14070460","article-title":"Anticancer activity of bee venom components against breast cancer","volume":"14","author":"Kwon","year":"2022","journal-title":"Toxins"},{"issue":"11","key":"10.1016\/j.intimp.2025.114703_bb0450","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.3390\/toxins7114758","article-title":"The protective effect of bee venom on fibrosis causing inflammatory diseases","volume":"7","author":"Lee","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0455","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10059-010-0028-9","article-title":"Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-\u03baB and AP-1-dependent MMP-9 expression","volume":"29","author":"Park","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2025.114703_bb0460","doi-asserted-by":"crossref","DOI":"10.1177\/1534735420944476","article-title":"Role of bee venom and melittin on restraining angiogenesis and metastasis in \u03b3-irradiated solid ehrlich carcinoma-bearing mice","volume":"19","author":"El Bakary","year":"2020","journal-title":"Integr. Cancer Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0465","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1254\/jphs.SC0070215","article-title":"Effects of melittin on the production of matrix metalloproteinase-1 and-3 in rheumatoid arthritic fibroblast-like synoviocytes","volume":"106","author":"Nah","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2025.114703_bb0470","article-title":"Anti-fibrinolytic activity of a metalloprotease inhibitor from bumblebee (Bombus ignitus) venom","volume":"245","author":"Kim","year":"2021","journal-title":"Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/vetsci10020119","article-title":"Therapeutic use of bee venom and potential applications in veterinary medicine","volume":"10","author":"Bava","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.intimp.2025.114703_bb0480","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2017.05.010","article-title":"Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy","volume":"402","author":"Rady","year":"2017","journal-title":"Cancer Lett."},{"issue":"14","key":"10.1016\/j.intimp.2025.114703_bb0485","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3390\/cancers15143714","article-title":"Can bee venom be used as anticancer agent in modern medicine?","volume":"15","author":"Ma\u0142ek","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0490","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/toxins16030117","article-title":"Bee venom: composition and anticancer properties","volume":"16","author":"Gajski","year":"2024","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0495","first-page":"93","article-title":"A matrix metalloproteinase 2 cleavable melittin\/avidin conjugate specifically targets tumor cells in vitro and in vivo","volume":"22","author":"Holle","year":"2003","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0500","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.etap.2013.06.009","article-title":"Melittin: a lytic peptide with anticancer properties","volume":"36","author":"Gajski","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0505","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/toxins7041126","article-title":"Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan","volume":"7","author":"Moreno","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0510","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxicon.2015.12.005","article-title":"Melittin induced cytogenetic damage, oxidative stress and changes in gene expression in human peripheral blood lymphocytes","volume":"110","author":"Gajski","year":"2016","journal-title":"Toxicon"},{"issue":"11","key":"10.1016\/j.intimp.2025.114703_bb0515","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/j.fct.2012.08.026","article-title":"Melittin has an inhibitory effect on TNF-\u03b1-induced migration of human aortic smooth muscle cells by blocking the MMP-9 expression","volume":"50","author":"Jeong","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0520","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.intimp.2015.02.021","article-title":"Melittin has a chondroprotective effect by inhibiting MMP-1 and MMP-8 expressions via blocking NF-\u03baB and AP-1 signaling pathway in chondrocytes","volume":"25","author":"Jeong","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0525","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/toxins13020105","article-title":"Animal venom for medical usage in pharmacopuncture in Korean medicine: current status and clinical implication","volume":"13","author":"Sung","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0530","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.toxicon.2014.11.233","article-title":"Scorpion venom components as potential candidates for drug development","volume":"93","author":"Ortiz","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2025.114703_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-2269-3","article-title":"In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model","volume":"5","author":"Salem","year":"2016","journal-title":"Springerplus"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0540","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3892\/ol.2015.4036","article-title":"In vitro analysis of the anticancer properties of scorpion venom in colorectal and breast cancer cell lines","volume":"11","author":"Al-Asmari","year":"2016","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0545","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yexmp.2016.11.006","article-title":"Role of angiotensin II and angiotensin type-1 receptor in scorpion venom-induced cardiac and aortic tissue inflammation","volume":"102","author":"Sifi","year":"2017","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0550","first-page":"5262729","article-title":"The activity of metalloproteases and serine proteases in various organs after Leiurus macroctenus envenomation","volume":"2023","author":"Gunas","year":"2023","journal-title":"Journal of Toxicology"},{"key":"10.1016\/j.intimp.2025.114703_bb0555","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00011-018-1177-0","article-title":"Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1. 3 channel blocker","volume":"67","author":"Taibi-Djennah","year":"2018","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0560","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10989-024-10635-5","article-title":"Chitosan-coated scorpion venom ameliorates acute lung injury caused by Klebsiella pneumoniae","volume":"30","author":"Oskay","year":"2024","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"13","key":"10.1016\/j.intimp.2025.114703_bb0565","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3390\/cancers15133388","article-title":"Diagnostic and therapeutic approaches for glioblastoma and neuroblastoma cancers using chlorotoxin nanoparticles","volume":"15","author":"Boltman","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0570","first-page":"233","article-title":"Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives","volume":"3","author":"Rap\u00f4so","year":"2017","journal-title":"Journal of Clinical and Translational Research"},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0575","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/psb.1837","article-title":"The next generation of venom-based drugs","volume":"31","author":"Greener","year":"2020","journal-title":"Prescriber"},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0580","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3390\/molecules27072219","article-title":"Anti-cancer activity of Buthus occitanus venom on hepatocellular carcinoma in 3D cell culture","volume":"27","author":"Lafnoune","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.114703_bb0585","article-title":"Cytokines and their regulators in rat lung following scorpion envenomation","volume":"X, 22","author":"Gunas","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2025.114703_bb0590","doi-asserted-by":"crossref","DOI":"10.7324\/JABB.2024.163558","article-title":"Cytokine disbalance in the rats\u2019 kidneys following Leiurus macroctenus envenomation","author":"Matkivska","year":"2024","journal-title":"J. Appl. Biol. Biotechnol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0595","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/toxins8020036","article-title":"Structure-activity relationship of chlorotoxin-like peptides","volume":"8","author":"Ali","year":"2016","journal-title":"Toxins"},{"issue":"12","key":"10.1016\/j.intimp.2025.114703_bb0600","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/toxins10120496","article-title":"Chlorotoxin\u2014A multimodal imaging platform for targeting glioma tumors","volume":"10","author":"Cohen","year":"2018","journal-title":"Toxins"},{"issue":"38","key":"10.1016\/j.intimp.2025.114703_bb0605","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.2174\/138161211798999375","article-title":"In vivo bio-imaging using chlorotoxin-based conjugates","volume":"17","author":"Stroud","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0610","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.01.002","article-title":"Arthropod venoms and cancer","volume":"57","author":"Heinen","year":"2011","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0615","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/eva.12963","article-title":"Cancer therapeutics inspired by defense mechanisms in the animal kingdom","volume":"13","author":"Noble","year":"2020","journal-title":"Evol. Appl."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0620","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/biomedicines8050118","article-title":"Scorpion venom: detriments and benefits","volume":"8","author":"Ahmadi","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0625","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2025.114703_bb0630","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0635","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000371493","article-title":"Systemic responses following brain injuries and inflammatory process activation induced by a neurotoxin of Androctonus scorpion venom","volume":"22","author":"Taibi-Djennah","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0640","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.117.245118","article-title":"Targeting KCa1. 1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis","volume":"365","author":"Tanner","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0645","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00000441-199210000-00008","article-title":"Loxoscelism","volume":"304","author":"Futrell","year":"1992","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0650","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.0022-202X.2005.23654.x","article-title":"Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression","volume":"124","author":"Tambourgi","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0655","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.jid.5700049","article-title":"Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by Loxosceles venom sphingomyelinase D","volume":"126","author":"Paix\u00e3o-Cavalcante","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153090","article-title":"Sphingomyelinase D from Loxosceles laeta venom induces the expression of MMP7 in human keratinocytes: contribution to dermonecrosis","volume":"11","author":"Correa","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0665","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/sj.jid.5700688","article-title":"Tetracycline protects against dermonecrosis induced by Loxosceles spider venom","volume":"127","author":"Paix\u00e3o-Cavalcante","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0670","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/toxins9030090","article-title":"Tetracycline reduces kidney damage induced by loxosceles spider venom","volume":"9","author":"Okamoto","year":"2017","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0675","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/14756366.2018.1546698","article-title":"Targeting Loxosceles spider sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism","volume":"34","author":"Lopes","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2025.114703_bb0680","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s00204-023-03602-4","article-title":"Role of ErbB and IL-1 signaling pathways in the dermonecrotic lesion induced by Loxosceles sphingomyelinases D","volume":"97","author":"Pinto","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114703_bb0685","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1007\/s00204-020-02830-2","article-title":"Cytotoxic and genotoxic effects on human keratinocytes triggered by sphingomyelinase D from Loxosceles venom","volume":"94","author":"da Silva","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2025.114703_bb0690","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s11101-017-9525-1","article-title":"Bufadienolides of Kalanchoe species: an overview of chemical structure, biological activity and prospects for pharmacological use","volume":"16","author":"Kolodziejczyk-Czepas","year":"2017","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.intimp.2025.114703_bb0695","doi-asserted-by":"crossref","first-page":"1014637","DOI":"10.3389\/fonc.2022.1014637","article-title":"A research update on the antitumor effects of active components of Chinese medicine ChanSu","volume":"12","author":"Jia","year":"2022","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0700","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/toxins13020105","article-title":"Animal venom for medical usage in pharmacopuncture in Korean medicine: current status and clinical implication","volume":"13","author":"Sung","year":"2021","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.intimp.2025.114703_bb0705","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3892\/ijo.2016.3667","article-title":"Inhibitory effect of bufalin combined with hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells","volume":"49","author":"Sheng","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0710","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/tox.20769","article-title":"Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways","volume":"29","author":"Chueh","year":"2014","journal-title":"Environ. Toxicol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114703_bb0715","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/toxins10080336","article-title":"The development of toad toxins as potential therapeutic agents","volume":"10","author":"Qi","year":"2018","journal-title":"Toxins"},{"issue":"18","key":"10.1016\/j.intimp.2025.114703_bb0720","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.3390\/ijms241813985","article-title":"Amphibian-derived natural anticancer peptides and proteins: mechanism of action, application strategies, and prospects","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0725","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15806\/j.issn.2311-8571.2014.0024","article-title":"Advancement in research of anti-cancer effects of toad venom (ChanSu) and perspectives","volume":"1","author":"Liu","year":"2015","journal-title":"World J. Tradi. Chin. Medi."},{"key":"10.1016\/j.intimp.2025.114703_bb0730","doi-asserted-by":"crossref","first-page":"1014637","DOI":"10.3389\/fonc.2022.1014637","article-title":"A research update on the antitumor effects of active components of Chinese medicine ChanSu","volume":"12","author":"Jia","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0735","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/tox.21896","article-title":"Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2\/\u22129-signaling pathways","volume":"30","author":"Chen","year":"2015","journal-title":"Environ. Toxicol."},{"issue":"06","key":"10.1016\/j.intimp.2025.114703_bb0740","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1142\/S0192415X15500718","article-title":"Bufalin inhibits NCI-H460 human lung cancer cell metastasis in vitro by inhibiting MAPKs, MMPs, and NF-\u03baB pathways","volume":"43","author":"Wu","year":"2015","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0745","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/ijo.2012.1683","article-title":"Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions","volume":"42","author":"Hong","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2025.114703_bb0750","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s10753-014-9828-y","article-title":"Bufalin, a bioactive component of the Chinese medicine chansu, inhibits inflammation and invasion of human rheumatoid arthritis fibroblast-like synoviocytes","volume":"37","author":"Rong","year":"2014","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0755","first-page":"631","article-title":"Molecular mechanisms underlying the antimetastatic activity of bufalin","volume":"8","author":"Wang","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.114703_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-13-185","article-title":"Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells","volume":"13","author":"Qiu","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0765","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1574892816666210201120324","article-title":"Effect of PI3K\/AKT\/mTOR signaling pathway on regulating and controlling the anti-invasion and metastasis of hepatoma cells by bufalin","volume":"16","author":"Sheng","year":"2021","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0770","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3892\/ijo.2015.3250","article-title":"The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt\/\u03b2-catenin signaling pathway","volume":"48","author":"Gai","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2025.114703_bb0775","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jep.2016.11.004","article-title":"Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro","volume":"194","author":"Huang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114703_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-12-57","article-title":"Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice","volume":"12","author":"Zhang","year":"2014","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0785","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7314\/APJCP.2012.13.1.399","article-title":"Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells","volume":"13","author":"Takai","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0790","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s10495-023-01819-3","article-title":"Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway","volume":"28","author":"Wang","year":"2023","journal-title":"Apoptosis"},{"issue":"15","key":"10.1016\/j.intimp.2025.114703_bb0795","doi-asserted-by":"crossref","first-page":"58","DOI":"10.14715\/cmb\/2023.69.15.9","article-title":"Cinobufotalin effect and mechanism on serum MMP-2, MMP-9, Beclin1, LC3-II in advanced NSCLC patients","volume":"69","author":"Yang","year":"2023","journal-title":"Cell. Mol. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.114703_bb0800","doi-asserted-by":"crossref","first-page":"24772","DOI":"10.3390\/ijms161024772","article-title":"Elevated STAT3 signaling-mediated upregulation of MMP-2\/9 confers enhanced invasion ability in multidrug-resistant breast cancer cells","volume":"16","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.intimp.2025.114703_bb0805","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.3390\/molecules28196783","article-title":"Bufotalin suppresses proliferation and metastasis of triple-negative breast cancer cells by promoting apoptosis and inhibiting the STAT3\/EMT axis","volume":"28","author":"Park","year":"2023","journal-title":"Molecules"},{"issue":"03","key":"10.1016\/j.intimp.2025.114703_bb0810","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1142\/S0192415X20500354","article-title":"Cinobufacini inhibits colon cancer invasion and metastasis via suppressing Wnt\/\u03b2-catenin signaling pathway and EMT","volume":"48","author":"Wang","year":"2020","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0815","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0049-3848(01)00416-9","article-title":"Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration","volume":"105","author":"Hong","year":"2002","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0820","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2008.10.010","article-title":"Integrin \u03b1v\u03b23-mediated transcriptional regulation of TIMP-1 in a human ovarian cancer cell line","volume":"377","author":"Kim","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0825","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jat.4544","article-title":"Snake venom toxins: potential anticancer therapeutics","volume":"44","author":"Offor","year":"2024","journal-title":"J. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0830","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/molecules23030692","article-title":"Anticancer activity of toxins from bee and snake venom\u2014an overview on ovarian cancer","volume":"23","author":"Moga","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0835","article-title":"Suppression of inflammation and arthritis by orally administrated cardiotoxin from Naja naja atra","volume":"2015","author":"Chen","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.intimp.2025.114703_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2013.01.004","article-title":"Inhibition of leukemic U937 cell growth by induction of apoptosis, cell cycle arrest and suppression of VEGF, MMP-2 and MMP-9 activities bycytotoxin protein NN-32 purified from Indian spectacled cobra (Naja naja) venom","volume":"65","author":"Das","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.intimp.2025.114703_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-2018-3","article-title":"Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines","volume":"17","author":"Attarde","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114703_bb0850","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.molimm.2006.05.001","article-title":"Saxatilin inhibits TNF-\u03b1-induced proliferation by suppressing AP-1-dependent IL-8 expression in the ovarian cancer cell line MDAH 2774","volume":"44","author":"Kim","year":"2007","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0855","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/650946","article-title":"Cardiotoxin III inhibits proliferation and migration of oral cancer cells through MAPK and MMP signaling","volume":"2013","author":"Yen","year":"2013","journal-title":"Sci. World J."},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0860","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5483\/BMBRep.2007.40.2.290","article-title":"Saxatilin, a snake venom disintegrin, suppresses TNF-\u03b1-induced ovarian cancer cell invasion","volume":"40","author":"Kim","year":"2007","journal-title":"BMB Rep."},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0865","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.toxicon.2004.08.002","article-title":"Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases","volume":"44","author":"Saravia-Otten","year":"2004","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0870","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-4827(03)00183-6","article-title":"Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis","volume":"288","author":"Wu","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.114703_bb0875","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/toxins13110800","article-title":"Observation of Bothrops atrox snake envenoming blister formation from five patients: pathophysiological insights","volume":"13","author":"Gimenes","year":"2021","journal-title":"Toxins"},{"issue":"7","key":"10.1016\/j.intimp.2025.114703_bb0880","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/biom11070921","article-title":"A metalloproteinase induces an inflammatory response in preadipocytes with the activation of COX signalling pathways and participation of endogenous phospholipases A2","volume":"11","author":"Janovits","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.intimp.2025.114703_bb0885","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coph.2008.11.007","article-title":"The application of toxins and venoms to cardiovascular drug discovery","volume":"9","author":"Hodgson","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0890","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CAD.0b013e32835f258d","article-title":"Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities","volume":"24","author":"Ji","year":"2013","journal-title":"Anti-Cancer Drugs"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114703_bb0895","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2011.10.020","article-title":"Antimetastatic potential of cardiotoxin III involves inactivation of PI3K\/Akt and p38 MAPK signaling pathways in human breast cancer MDA-MB-231 cells","volume":"90","author":"Lin","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114703_bb0900","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1007\/s00253-016-7610-9","article-title":"Snake venom toxins: toxicity and medicinal applications","volume":"100","author":"Chan","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2025.114703_bb0905","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.biopha.2018.01.116","article-title":"An aqueous extract of Nomura\u2019s jellyfish ameliorates inflammatory responses in lipopolysaccharide-stimulated RAW264. 7 cells and a zebrafish model of inflammation","volume":"100","author":"Hwang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114703_bb0910","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10499-021-00673-x","article-title":"Relationship between expression of matrix metalloproteinase-9 and feeding on jellyfish in Pampus argenteus","volume":"29","author":"Zhou","year":"2021","journal-title":"Aquac. Int."},{"issue":"24","key":"10.1016\/j.intimp.2025.114703_bb0915","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.3390\/molecules25245979","article-title":"Sea anemone Heteractis crispa actinoporin demonstrates in vitro anticancer activities and prevents HT-29 colorectal cancer cell migration","volume":"25","author":"Kvetkina","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0920","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/toxins11030156","article-title":"Inhibitory effect of metalloproteinase inhibitors on skin cell inflammation induced by jellyfish Nemopilema nomurai nematocyst venom","volume":"11","author":"Li","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.intimp.2025.114703_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113192","article-title":"Jellyfish Nemopilema nomurai causes myotoxicity through the metalloprotease component of venom","volume":"151","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2025.114703_bb0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057658","article-title":"Protective effect of tetracycline against dermal toxicity induced by jellyfish venom","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2025.114703_bb0935","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1038\/s41598-020-75269-1","article-title":"Protective effect of epigallocatechin-3-gallate (EGCG) on toxic metalloproteinases-mediated skin damage induced by scyphozoan jellyfish envenomation","volume":"10","author":"Hwang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114703_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107266","article-title":"Nemopilema nomurai jellyfish venom attenuates phenotypic modulation of PDGF BB-induced vascular smooth muscle cells and \u03ba-carrageenan-induced rat tail thrombosis","volume":"233","author":"Yang","year":"2023","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.intimp.2025.114703_bb0945","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/md22050205","article-title":"Exploring the efficacy of Hydroxybenzoic acid derivatives in mitigating jellyfish toxin-induced skin damage: insights into protective and reparative mechanisms","volume":"22","author":"Geng","year":"2024","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.intimp.2025.114703_bb0950","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.944265","article-title":"Jellyfish stings: A review of skin symptoms, pathophysiology, and management","volume":"30","author":"Peng","year":"2024","journal-title":"Med. Sci. Monitor: Int. Med. J. Experiment. Clin. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925006939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:19:00Z","timestamp":1747653540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925006939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":190,"alternative-id":["S1567576925006939"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114703","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on animal venom-based matrix metalloproteinase modulators and their therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114703"}}